Jasper Therapeutics, Inc. — Form D

Jasper Therapeutics, Inc. of REDWOOD CITY, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-08-05. The offering totals $132.0M, of which $132.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-08-05
• Form: D
• Accession: 0001213900-26-085315
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $132.0M
• Amount sold: $132.0M
• Investors: 40
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-593140

Issuer

• Name: Jasper Therapeutics, Inc.
• CIK: 0001788028
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 2200 BRIDGE PKWY SUITE #102, REDWOOD CITY, CA, 94065
• Phone: 650-549-1400

Officers, directors & promoters (10)

More

• CIK 1788028 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search